Hypoxia during air travel in adults with pulmonary disease

The American Journal of the Medical Sciences
Lawrence C Mohr

Abstract

At the present time, commercial aircraft cabins are required to be pressurized to the equivalent of 8,000 feet or less. Although in-flight medical emergencies are infrequent, some adults with pulmonary disease may experience significant physiological stress, exacerbation of their underlying illness, and severe hypoxemia during air travel. A careful preflight medical evaluation is essential to determine which patients with pulmonary disease can fly safely, which patients require supplemental oxygen, and which patients should not fly at all. All adults with pulmonary disease who have a preflight arterial oxygen tension of less than 70 mm Hg or a preflight pulse oximetry saturation of less than 92% should receive supplemental oxygen during air travel. The hypoxia altitude simulation test and the 6-minute walk test are useful when additional evaluation for supplemental in-flight oxygen is needed. Patients with an unstable condition, an acute exacerbation of their pulmonary disease, severe pulmonary hypertension (Class III and Class IV), or an active pneumothorax should not fly.

References

Sep 29, 1978·JAMA : the Journal of the American Medical Association·W R Barclay
Sep 1, 1991·Archives of Internal Medicine·T A DillardB W Berg
Mar 1, 1989·The American Journal of Emergency Medicine·R Shesser
Sep 1, 1989·Annals of Internal Medicine·T A DillardW J Mehm
Mar 3, 1989·JAMA : the Journal of the American Medical Association·R O Cummins, J A Schubach
Mar 1, 1984·Chest·S Rounds, N S Hill
Apr 16, 1983·British Medical Journal·F J Mills, R M Harding
Apr 23, 1983·British Medical Journal·F J Mills, R M Harding
Apr 1, 1984·Annals of Internal Medicine·J S SchwartzK M Moser
Nov 25, 2000·BMJ : British Medical Journal·T Goodwin
Mar 30, 2002·Thorax·UNKNOWN British Thoracic Society Standards of Care Committee
Apr 5, 2002·The New England Journal of Medicine·Mark A Gendreau, Charles DeJohn
Apr 26, 2002·Pediatric Emergency Care·Andy P LeeNatalie L Relles
Nov 13, 2002·Annual Review of Public Health·Roy L DeHart
Nov 26, 2002·BMJ : British Medical Journal·Michael D L Morgan
May 21, 2003·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Bruce G Ward, Stephen J Broe
Apr 23, 2004·Archives of Disease in Childhood·M P Samuels
Apr 2, 2005·The European Respiratory Journal·A AkerøO H Skjønsberg
Feb 4, 2006·Current Opinion in Pulmonary Medicine·Leigh M Seccombe, Matthew J Peters
Apr 3, 2007·The European Respiratory Journal·A M Luks, E R Swenson
Jul 6, 2007·The New England Journal of Medicine·J Michael MuhmAleksandra McMullen

❮ Previous
Next ❯

Citations

May 3, 2011·Zeitschrift für Rheumatologie·U Lange
Nov 9, 2010·Internal and Emergency Medicine·Israel Gavish, Benjamin Brenner
Mar 31, 2012·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Rajendrakumar PatelSumir P Sahgal
Sep 21, 2013·Lung India : Official Organ of Indian Chest Society·Dheeraj GuptaUNKNOWN S. K. Jindal for the COPD Guidelines Working Group
Oct 5, 2014·The Journal of Emergency Medicine·Kellen T GalsterFernando R Silva
Mar 25, 2011·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·B Osona Rodríguez de TorresUNKNOWN Grupo de Trabajo de Técnicas de la Sociedad Española de Neumología Pediátrica
May 31, 2011·Journal of Cardiothoracic and Vascular Anesthesia·Johann Strumpher, Eric Jacobsohn
Dec 17, 2009·La Presse médicale·Frédéric LapostolleFrédéric Adnet
Sep 5, 2013·Air Medical Journal·Andy BunchWilliam Brady
Feb 26, 2013·Orvosi hetilap·Péter FelkaiIldikó Gyarmati
Nov 29, 2011·Critical Care Nursing Clinics of North America·Mae M Centeno
Oct 29, 2011·Pulmonary Circulation·Melanie ThammHossein A Ghofrani
Jul 20, 2011·Nature Reviews. Cardiology·Dermot S O'CallaghanMarc Humbert
Jun 15, 2018·European Respiratory Review : an Official Journal of the European Respiratory Society·Begum ErganStefano Nava

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
H OlschewskiAerosolized Iloprost Randomized Study Group
The New England Journal of Medicine
Nazzareno GalièSildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group
© 2021 Meta ULC. All rights reserved